Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study

Neurology

Volumn 46, Issue 2, 1996, Pages 492-498

  Olanow, C W ^a   Good, P F ^b   Shinotoh, H ^c   Hewitt, K A ^c   Vingerhoets, F ^c   Snow, B J ^c   Beal, M F ^d   Calne, D B ^c   Perl, D P ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; IRON; LEVODOPA; MANGANESE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BRADYKINESIA; DYSTONIA; GLIOSIS; HEAVY METAL POISONING; MALE; MUSCLE RIGIDITY; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL;

EID: 0029937779     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.492     Document Type: Article

References (61)

1. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837;1:41-42.
2. Embden H. Zur Kentniss der metallischen Nervengifte. Deutsch Med Wochenschr 1901;27:795-796.
3. von Jaksch R. Uber mangantoxikosen und maganophobie. Munchen Med Wochenschr. 1907;54:969-972.
4. Edsall DL, Wilbur FP, Drinker CK. The occurrence, course and prevention of chronic manganese poisoning. J Ind Hyg 1919;1:183-193.
5. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967;17:128-136.
6. Calne DB, Chu NS, Hung CC, Lu CS, Olanow CW. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994;44:1583-1586.
7. Rosenstock HA, Simons DG, Meyer JS. Chronic manganism; neurologic and laboratory studies during treatment with levodopa. JAMA 1971;217:1354-1358.
8. Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning: treatment with L-dopa and 5-OH tryptophane. N Engl J Med 1970;282:5-10.
9. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59-64.
10. Greenhouse AH. Manganese intoxication in the United States. Trans Am Neurol Assoc 1971:96:248-249.
11. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.
12. Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 1969;19:674-684.
13. Canavan M, Cobb S, Drinker CK. Chronic manganese poisoning: report of a case with autopsy. Arch Neurol Psychiatry 1934;32:501-512.
14. Flinn RH, Neal PA, Fulton WB. Industrial manganese poisoning. J Ind Hyg Toxicol 1941;23:374-387.
15. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35.
16. Smyth LT, Ruhf RC, Whitman NE, et al. Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy. J Occup Med 1973;15:101-109.
17. Cotzias GC, Horiuchi K, Fuenzalida S, et al. Chronic manganese poisoning: clearance of tissue manganese concentrations with persistence of the neurological picture. Neurology 1968; 26:647-651.
18. Larsen NA, Pakkenberg H, Damsgaard E, Heydorn K. Topographical distribution of arsenic, manganese, and selenium in the normal human brain. J Neurol Sci 1979;42:407-416.
19. Bonilla E, Salazar E, Joaquin J, et al. The regional distribution of manganese in the normal human brain. Neurochem Res 1982;7:221-227.
20. Suzuki Y, Mouri Y, Suzuki K, et al. Study of subacute toxicity of manganese dioxide in monkeys. Tokoshima J Exp 1975;22: 5-10.
21. Larsen NA, Pakkenberg H, Damsgaard E, et al. Distribution of arsenic, manganese and selenium in the human brain in chronic renal insufficiency, Parkinson's disease and amyotrophic lateral sclerosis. J Neurol Sci 1981;51:437-446.
22. Dastur DK, Mangahania DK, Raghavendran KV. Distribution and fate of 54Mn in the monkey: studies of different parts of the central nervous system and other organs. J Clin Invest 1968;50:9-20.
23. Newland MC, Ceckler TL, Kordower JH, et al. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989;106:251-258.
24. Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986; 70:273-278.
25. Ashizawa R. Uber einen Sektionsfall von chronischer manganvergiftung. Jpn J Med Sci Trans Intern Med Peditt Psychiat 1927;1:173-191.
26. Parnitzke KH, Peiffer J. Zur Klinik und pathologischen Anatomie der chronischen Braunsteinvergiftung. Arch Psychiat Zeitschr Neurol 1954;192:405-429.
27. Stadler HZ. Zur Histopathologie des Gehims bei manganvergiftung. Zbl Ges Neurol Psychiat 1936;154:62-76.
28. Mella H. The experimental production of basal ganglion symptomatology in Macacus Rhesus. Arch Neurol Psychiatry 1924; 11:405-417.
29. Pentschew A, Ebner F, Kovatch R. Experimental manganese encephalopathy in monkeys: a preliminary report. J Neuropathol Exp Neurol 1963;22:488-499.
30. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnoses of idiopathic Parkinson's disease: a clinico-pathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 54:388-396.
31. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin North Am 1992;405-420.
32. Kurlan R, Kim MN, Gash DM. Oral-levodopa dose response study in MPTP-induced hemiparkinsonian monkeys: assessment with new rating scale for monkey parkinsonism. Mov Disord 1991;6:111-118.
33. Pearse AGE. Histochemistry - theoretical and applied. Edinburgh: Churchill Livingstone, 1985.
34. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992;31:286-292.
35. Beal MF, Matson WR, Swartz KJ, Gamache PH, Bird ED. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 1990;55:1327-1339.
36. Gibb WRG, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991;54:388-396.
37. Kish SJ, Shannak K, Homykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease-pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
38. Jenner PJ, Marsden CD. MPTP-induced parkinsonism: a model of Parkinson's disease and its relevance to the disease process. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. 2nd ed. Baltimore: Williams and Wilkins, 1993:55-75.
39. Shinotoh H, Snow BJ, Hewitt KA, et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995;45:1199-1204.
40. Martin WRW, Stoessel AJ, Adam MJ, et al. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism. Adv Neurol 1986;45:95-98.
41. Sawle GV, Brooks DJ, Ibanez V, Frackowiak RSJ. Striatal D2 receptor density is inversely proportional to dopa uptake in untreated hemi-Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:177.
42. Huang CC, Chu NS, Lu CS, et al. Chronic manganese intoxication. Arch Neurol 1989;46:1104-1106.
43. Wolters ECh, Huang CC, Clark C, et al. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26: 647-651.
44. Newland M, Cox C, Hamada R, et al. The clearance of manganese chloride in the primate. Fundam App Toxicol 1987;9: 314-328.
45. Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-875.
46. Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM. Differential vulnerability of primate caudateputamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1992;89:3859-3863.
47. Roels H, Lauwerys R, Buchet J-P, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system and some biological indices. Am J Indust Med 1987;11:307-327.
48. Lista A, Abarca J, Ramos C, Daniels AJ. Rat striatal dopamine and tetrahydrobiopterin content following an intrastriatal injection of manganese chloride. Life Sci 1986;38:2121-2127.
49. 2+ on striatal and nigral synthesis and levels of dopamine and cofactor. Neurotoxicol Teratol 1991;13:483-487.
50. Roberts R, Sandra A, Siek GC, et al. Studies of the mechanism of iron transport across the blood brain barrier. Ann Neurol 1992;32:43-50.
51. Aschner M, Aschner JL. Manganese transport across the blood brain barrier: relationship to iron homeostasis. Brain Res Bull 1990;24:857-860.
52. Hill JM, Ruff MR, Weber RJ, Pert C. Transferrin receptors in the rat brain: neuropeptide like pattern and relation to iron distribution. Proc Natl Acad Sci USA 1985;82:4553-4557.
53. Dwork AJ, Lawler G, Zybert P, et al. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res 1990;518:31-39.
54. Banks WA, Kastin AJ, Fasold MB, et al. Studies on the slow bi-directional transport of iron and transferrin across the blood brain barrier. Brain Res Bull 1988;21:881-885.
55. Donaldson J, Labella FS, Gesser D. Enhanced autooxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 1981;2:53-64.
56. Liccione JJ, Maines MD. Manganese-mediated increase in rat brain mitochondrial cytochrome P-450 and drug metabolism activity: susceptibility of the striatum. J Pharmacol Exp Ther 1989;248:222-228.
57. Errikson M, Heilbronn E. Changes in the redox state of neuroblastoma cells after manganese exposure. Arch Toxicol 1983;54:53-59.
58. Liccione JJ, Maines MD. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 1988;247:156-161.
59. Parenti M, Rusconi L, Cappabianca V, Parati EA, Groppetti A. A role of dopamine in manganese neurotoxicity. Brain Res 1988;473:236-240.
60. Gutteridge JMC, Quinlan GJ, Clark I, Halliwell B. Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 1985;835:441-447.
61. Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. Manganese injection into the striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 1993; 120:89-94.